Research papers
- Kim, S.K., Cargioli, T.G., Machluf, M., Yang, W., Sun, Y., Al-Hashem, R., Kim, S.U., Black, P.M. & Carroll, R.S. PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clinical cancer research: an official journal of the American Association for Cancer Research 11, 5965-5970 (2005).
- Duvshani-Eshet, M. & Machluf, M. Therapeutic ultrasound optimization for gene delivery: a key factor achieving nuclear DNA localization. Journal of controlled release: official journal of the Controlled Release Society 108, 513-528 (2005).
- Benny, O., Duvshani-Eshet, M., Cargioli, T., Bello, L., Bikfalvi, A., Carroll, R.S. & Machluf, M. Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth. Clinical cancer research: an official journal of the American Association for Cancer Research 11, 768-776 (2005).
- Kessler, O., Shraga-Heled, N., Lange, T., Gutmann-Raviv, N., Sabo, E., Baruch, L., Machluf, M. & Neufeld, G. Semaphorin-3F is an inhibitor of tumor angiogenesis. Cancer research 64, 1008-1015 (2004).
- Seagal, J., Edry, E., Keren, Z., Leider, N., Benny, O., Machluf, M. & Melamed, D. A fail-safe mechanism for negative selection of isotype-switched B cell precursors is regulated by the Fas/FasL pathway. The Journal of experimental medicine 198, 1609-1619 (2003).
- Schuch, G., Heymach, J.V., Nomi, M., Machluf, M., Force, J., Atala, A., Eder, J.P., Jr., Folkman, J. & Soker, S. Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. Cancer research 63, 8345-8350 (2003).
- Machluf, M., Orsola, A., Boorjian, S., Kershen, R. & Atala, A. Microencapsulation of Leydig cells: a system for testosterone supplementation. Endocrinology 144, 4975-4979 (2003).
- Lange, T., Guttmann-Raviv, N., Baruch, L., Machluf, M. & Neufeld, G. VEGF162, a new heparin-binding vascular endothelial growth factor splice form that is expressed in transformed human cells. The Journal of biological chemistry 278, 17164-17169 (2003).
- Smith, R.C., Machluf, M., Bromley, P., Atala, A. & Walsh, K. Spatial and temporal control of transgene expression through ultrasound-mediated induction of the heat shock protein 70B promoter in vivo. Human gene therapy 13, 697-706 (2002).
- Schuch, G., Machluf, M., Bartsch, G., Jr., Nomi, M., Richard, H., Atala, A. & Soker, S. In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo. Blood 100, 4622-4628 (2002).
- Joki, T., Machluf, M., Atala, A., Zhu, J., Seyfried, N.T., Dunn, I.F., Abe, T., Carroll, R.S. & Black, P.M. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nature biotechnology 19, 35-39 (2001).
- Bello, L., Lucini, V., Carrabba, G., Giussani, C., Machluf, M., Pluderi, M., Nikas, D., Zhang, J., Tomei, G. & Villani, R.M. Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. Cancer research 61, 8730-8736 (2001).
Review papers
- Machluf, M. & Carroll, R.S. Cell-based delivery systems for antiangiogenic therapy. Biotechnology & genetic engineering reviews 20, 183-195 (2003).
- Carroll, R.S. & Machluf, M. Bioreactors for Decreasing the Growth of Brain Tumors. The Scientific World Journal 1, 194-195 (2001).
Book chapters
- Machluf, M. Protein therapeutic delivery using encapsulated cell platform in Applications of cell immobilisation biotechnology (Editors: Nedovi, V.; Willaert, R.). Springer: Dordrecht, 2005; p vi, 573 p.
- Machluf, M. Cell based delivery system for antiangiogenic therapy in Biotechnology & genetic engineering reviews. Intercept Nottingham University Press: Newcastle upon Tyne Nottingham, 2003; Vol. 20, pp 183-198.
- Machluf, M., & Atala, T. Tissue engineering of the testis in Methods of tissue engineering. Academic Press: San Diego, CA, 2001; p xli, 1285 p.